Literature DB >> 32759994

A FcɣRIIa polymorphism has a HLA-B57 and HLA-B27 independent effect on HIV disease outcome.

Raphael Carapito1,2, Luzia Mayr3, Anne Molitor3, Martin Verniquet3, Sylvie Schmidt3, Ouria Tahar3,4, Marialuisa Partisani5, David Rey5, Olivier Lambotte6,7, Seiamak Bahram3,4, Christiane Moog8,9.   

Abstract

Fcɣ receptors (FcɣRs) are key immune regulatory receptors that connect antibody-mediated immune responses to cellular effector functions. They are involved in the control of various immune functions including responses to infections. Genetic polymorphisms of FcɣRs coding genes (FCGR) have been associated with the regulation of HIV infection and progression. In this study, we analyzed the potential impact of five candidate FcɣR SNPs on viral control by genotyping 251 HIV controllers and 250 progressors. The rs10800309 AA genotype of the FcɣRIIa coding gene FCGR2A was found to be significantly associated with HIV control and this association was independent of HLA-B57 and HLA-B27 (OR, 2.84; 95% CI, 1.20-6.89; Pcor = 0.033). We further confirmed the functional role of this polymorphism by showing an association of this same AA genotype with an increased in vitro FcɣRII expression on myeloid cells including dendritic cells (P = 0.0032). Together, these results suggest that the AA genotype of rs10800309 confers an improved immune response through FcɣRII upregulation and that this polymorphism may serve as an additional predictive marker of HIV control.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32759994     DOI: 10.1038/s41435-020-0106-8

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  1 in total

1.  Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.

Authors:  Shuying S Li; Peter B Gilbert; Lindsay N Carpp; Chul-Woo Pyo; Holly Janes; Youyi Fong; Xiaoying Shen; Scott D Neidich; Derrick Goodman; Allan deCamp; Kristen W Cohen; Guido Ferrari; Scott M Hammer; Magdalena E Sobieszczyk; Mark J Mulligan; Susan P Buchbinder; Michael C Keefer; Edwin DeJesus; Richard M Novak; Ian Frank; M Juliana McElrath; Georgia D Tomaras; Daniel E Geraghty; Xinxia Peng
Journal:  J Virol       Date:  2019-10-15       Impact factor: 6.549

  1 in total
  2 in total

1.  FcγR Genetic Variation and HIV-1 Vaccine Efficacy: Context And Considerations.

Authors:  Ria Lassaunière; Caroline T Tiemessen
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

Review 2.  Fc receptors and the diversity of antibody responses to HIV infection and vaccination.

Authors:  Li-Yun Lin; Raphael Carapito; Bin Su; Christiane Moog
Journal:  Genes Immun       Date:  2022-06-10       Impact factor: 4.248

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.